Insider Trading activities at Paratek Pharmaceuticals, Inc. (NOVC)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Paratek Pharmaceuticals, Inc. (NOVC) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Paratek Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1178711.

Total stock buying since 2015: $13,649,658.
Total stock sales since 2015: $8,749,499.
Total stock option exercises since 2015: $539,506.


14 insiders reported insider trading activities at Paratek Pharmaceuticals, Inc. (NOVC):
Insider trading activities of Franson Timothy R
Insider trading activities of Brenner Randall B.
Insider trading activities of Omega Fund Iv, L.p.
Insider trading activities of Hbm Healthcare Investments (cayman) Ltd.
Insider trading activities of Stein Jeffrey
Insider trading activities of Radie Robert S
Insider trading activities of Bigham Michael
Insider trading activities of Haskel William M.
Insider trading activities of Pagan Douglas W.
Insider trading activities of Dondero James D
Insider trading activities of Dietz Thomas John
Insider trading activities of Loh Evan
Insider trading activities of Lim Richard J.
Insider trading activities of Woodrow Adam

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Paratek Pharmaceuticals, Inc. (NOVC).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2023 788,500 $1,282,055 156,346 $339,620 0 $0
2022 0 $0 363,059 $823,217 0 $0
2021 0 $0 364,125 $1,928,878 0 $0
2020 0 $0 252,814 $1,575,276 39,479 $169,759
2019 0 $0 87,467 $372,475 0 $0
2018 0 $0 223,325 $2,318,016 23,255 $99,996
2017 0 $0 35,932 $756,311 62,733 $269,751
2016 943,076 $12,269,008 0 $0 0 $0
2015 6,000 $98,595 20,580 $635,706 0 $0

Table 2. Monthly summary of insider trading at Paratek Pharmaceuticals, Inc. (NOVC).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2023-08 0 $0 142,346 $313,160 0 $0
2023-03 788,500 $1,282,055 0 $0 0 $0
2023-02 0 $0 14,000 $26,460 0 $0
2022-12 0 $0 228,474 $449,536 0 $0
2022-10 0 $0 19,368 $67,206 0 $0
2022-08 0 $0 115,217 $306,475 0 $0
2021-12 0 $0 216,828 $937,006 0 $0
2021-08 0 $0 95,394 $488,415 0 $0
2021-06 0 $0 51,903 $503,457 0 $0
2020-12 0 $0 137,880 $938,836 0 $0
2020-11 0 $0 77,427 $459,141 0 $0
2020-10 0 $0 0 $0 39,479 $169,759
2020-05 0 $0 37,507 $177,299 0 $0
2019-12 0 $0 28,057 $86,975 0 $0
2019-10 0 $0 42,128 $164,757 0 $0
2019-02 0 $0 17,282 $120,743 0 $0
2018-12 0 $0 40,038 $250,878 0 $0
2018-10 0 $0 66,537 $636,900 0 $0
2018-07 0 $0 41,823 $416,975 0 $0
2018-04 0 $0 31,082 $394,739 0 $0
2018-02 0 $0 43,845 $618,524 23,255 $99,996
2017-07 0 $0 19,826 $467,475 62,733 $269,751
2017-06 0 $0 4,595 $114,875 0 $0
2017-02 0 $0 11,511 $173,961 0 $0

Table 3. Detailed insider trading at Paratek Pharmaceuticals, Inc. (NOVC)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2023-08-09 Brenner Randall B. (Chief Development & Regulatory) Sale 27,603 2.20 60,726
2023-08-09 Loh Evan (CEO) Sale 48,967 2.20 107,727
2023-08-09 Haskel William M. (CLO, General Counsel & Sec.) Sale 34,526 2.20 75,957
2023-08-09 Bigham Michael (Exec. Chairman of the Board) Sale 31,250 2.20 68,750
2023-03-23 Dondero James D (10% Owner) Buy 100,000 1.73 173,000
2023-03-22 Dondero James D (10% Owner) Buy 106,000 1.77 187,620
2023-03-21 Dondero James D (10% Owner) Buy 242,500 1.74 421,950
2023-03-20 Dondero James D (10% Owner) Buy 105,137 1.40 147,191
2023-03-17 Dondero James D (10% Owner) Buy 234,863 1.50 352,294
2023-02-21 Stein Jeffrey Sale 7,000 1.90 13,300
2023-02-21 Franson Timothy R Sale 7,000 1.88 13,160
2022-12-13 Brenner Randall B. (Chief Development & Regulatory) Sale 18,177 1.96 35,626
2022-12-13 Woodrow Adam (President & Chief Commercial) Sale 6,253 1.96 12,255
2022-12-13 Loh Evan (CEO) Sale 61,919 1.96 121,361
2022-12-13 Haskel William M. (CLO, General Counsel & Sec.) Sale 23,584 1.96 46,224
2022-12-13 Bigham Michael (Exec. Chairman of the Board) Sale 31,891 1.96 62,506
2022-12-12 Brenner Randall B. (Chief Development & Regulatory) Sale 11,105 1.98 21,987
2022-12-12 Woodrow Adam (President & Chief Commercial) Sale 3,820 1.98 7,563
2022-12-12 Loh Evan (CEO) Sale 37,831 1.98 74,905
2022-12-12 Haskel William M. (CLO, General Counsel & Sec.) Sale 14,410 1.98 28,531
2022-12-12 Bigham Michael (Exec. Chairman of the Board) Sale 19,484 1.98 38,578
2022-10-28 Woodrow Adam (President & Chief Commercial) Sale 4,563 3.47 15,833
2022-10-28 Loh Evan (CEO) Sale 8,805 3.47 30,553
2022-10-28 Bigham Michael (Exec. Chairman of the Board) Sale 6,000 3.47 20,820
2022-08-09 Brenner Randall B. (Chief Development & Regulatory) Sale 19,608 2.66 52,157
2022-08-09 Loh Evan (CEO) Sale 44,519 2.66 118,420
2022-08-09 Haskel William M. (CLO, General Counsel & Sec.) Sale 22,453 2.66 59,724
2022-08-09 Bigham Michael (Exec. Chairman of the Board) Sale 28,637 2.66 76,174
2021-12-15 Brenner Randall B. (Chief Development & Regulatory) Sale 15,780 4.27 67,380
2021-12-15 Woodrow Adam (President & Chief Commercial) Sale 22,624 4.27 96,604
2021-12-15 Loh Evan (CEO) Sale 49,259 4.27 210,335
2021-12-15 Haskel William M. (CLO, General Counsel & Sec.) Sale 17,178 4.27 73,350
2021-12-15 Bigham Michael (Exec. Chairman of the Board) Sale 17,819 4.27 76,087
2021-12-14 Brenner Randall B. (Chief Development & Regulatory) Sale 7,635 4.37 33,364
2021-12-14 Woodrow Adam (President & Chief Commercial) Sale 10,946 4.37 47,834
2021-12-14 Loh Evan (CEO) Sale 23,834 4.37 104,154
2021-12-14 Haskel William M. (CLO, General Counsel & Sec.) Sale 8,312 4.37 36,323
2021-12-14 Bigham Michael (Exec. Chairman of the Board) Sale 8,622 4.37 37,678
2021-12-13 Brenner Randall B. (Chief Development & Regulatory) Sale 4,479 4.42 19,797
2021-12-13 Woodrow Adam (President & Chief Commercial) Sale 6,422 4.42 28,385
2021-12-13 Loh Evan (CEO) Sale 13,983 4.42 61,804
2021-12-13 Haskel William M. (CLO, General Counsel & Sec.) Sale 4,876 4.42 21,551
2021-12-13 Bigham Michael (Exec. Chairman of the Board) Sale 5,059 4.42 22,360
2021-08-17 Brenner Randall B. (Chief Development & Regulatory) Sale 8,766 5.12 44,881
2021-08-17 Woodrow Adam (President & Chief Commercial) Sale 10,975 5.12 56,192
2021-08-17 Loh Evan (CEO) Sale 33,931 5.12 173,726
2021-08-17 Haskel William M. (CLO, General Counsel & Sec.) Sale 9,692 5.12 49,623
2021-08-17 Bigham Michael (Exec. Chairman of the Board) Sale 32,030 5.12 163,993
2021-06-04 Brenner Randall B. (Chief Development & Regulatory) Sale 9,978 9.70 96,786
2021-06-04 Haskel William M. (CLO, General Counsel & Sec.) Sale 7,561 9.70 73,341
2021-06-04 Bigham Michael (Exec. Chairman of the Board) Sale 34,364 9.70 333,330
2020-12-14 Brenner Randall B. (Chief Development & Regulatory) Sale 8,760 6.71 58,779
2020-12-14 Woodrow Adam (President & Chief Commercial) Sale 12,855 6.71 86,257
2020-12-14 Loh Evan (CEO) Sale 26,415 6.71 177,244
2020-12-14 Haskel William M. (CLO, General Counsel & Sec.) Sale 6,842 6.71 45,909
2020-12-14 Bigham Michael (Exec. Chairman of the Board) Sale 26,063 6.71 174,882
2020-12-11 Brenner Randall B. (Chief Development & Regulatory) Sale 6,164 6.95 42,839
2020-12-11 Woodrow Adam (President & Chief Commercial) Sale 9,045 6.95 62,862
2020-12-11 Loh Evan (CEO) Sale 18,585 6.95 129,165
2020-12-11 Haskel William M. (CLO, General Counsel & Sec.) Sale 4,814 6.95 33,457
2020-12-11 Bigham Michael (Exec. Chairman of the Board) Sale 18,337 6.95 127,442
2020-11-13 Brenner Randall B. (Chief Development & Regulatory) Sale 8,357 5.93 49,557
2020-11-13 Woodrow Adam (President & Chief Commercial) Sale 15,000 5.93 88,950
2020-11-13 Loh Evan (CEO) Sale 20,928 5.93 124,103
2020-11-13 Haskel William M. (CLO, General Counsel & Sec.) Sale 6,892 5.93 40,869
2020-11-13 Bigham Michael (Exec. Chairman of the Board) Sale 26,250 5.93 155,662
2020-10-29 Loh Evan (CEO) Option Ex 39,479 4.30 169,759
2020-05-12 Brenner Randall B. (Chief Development & Regulatory) Sale 6,198 4.75 29,440
2020-05-12 Woodrow Adam (President & Chief Commercial) Sale 4,798 4.75 22,790
2020-05-12 Loh Evan (CEO) Sale 9,595 4.75 45,576
2020-05-12 Haskel William M. (Sr. VP, Sec. & General Counsel) Sale 4,666 4.75 22,163
2020-05-12 Bigham Michael (Exec. Chairman of the Board) Sale 12,250 4.68 57,330
2019-12-12 Brenner Randall B. (Chief Development & Regulatory) Sale 6,278 3.10 19,461
2019-12-12 Woodrow Adam (President & Chief Commercial) Sale 4,401 3.10 13,643
2019-12-12 Loh Evan (CEO) Sale 14,514 3.10 44,993
2019-12-12 Haskel William M. (Sr. VP, Sec. & General Counsel) Sale 2,864 3.10 8,878
2019-10-08 Brenner Randall B. (Chief Development & Regulatory) Sale 5,049 3.82 19,287
2019-10-08 Woodrow Adam (President & Chief Commercial) Sale 5,322 3.82 20,330
2019-10-08 Loh Evan (CEO) Sale 7,818 3.82 29,864
2019-10-03 Brenner Randall B. (Chief Development & Regulatory) Sale 7,674 3.98 30,542
2019-10-03 Loh Evan (CEO) Sale 16,265 3.98 64,734
2019-02-15 Radie Robert S (Director) Sale 3,750 7.14 26,775
2019-02-15 Dietz Thomas John (Director) Sale 3,000 7.14 21,420
2019-02-15 Stein Jeffrey (Director) Sale 3,375 7.14 24,097
2019-02-05 Woodrow Adam (VP & Chief Commercial Officer) Sale 3,331 6.77 22,550
2019-02-05 Pagan Douglas W. (Chief Financial Officer) Sale 2,495 6.77 16,891
2019-02-05 Haskel William M. (Sr. VP, Sec. & General Counsel) Sale 1,331 6.77 9,010
2018-12-21 Dietz Thomas John (Director) Sale 9,330 5.01 46,743
2018-12-13 Loh Evan (President, COO and CMO) Sale 6,000 6.27 37,620
2018-12-13 Haskel William M. (Sr. VP, Sec. & General Counsel) Sale 1,000 6.25 6,250
2018-12-12 Woodrow Adam (VP & Chief Commercial Officer) Sale 3,733 6.76 25,235
2018-12-12 Pagan Douglas W. (Chief Financial Officer) Sale 2,918 6.76 19,725
2018-12-12 Loh Evan (President, COO and CMO) Sale 5,525 6.76 37,349
2018-12-12 Haskel William M. (Sr. VP, Sec. & General Counsel) Sale 3,132 6.76 21,172
2018-12-12 Bigham Michael (Chairman and CEO) Sale 8,400 6.76 56,784
2018-10-15 Woodrow Adam (VP & Chief Commercial Officer) Sale 2,659 8.96 23,824
2018-10-15 Pagan Douglas W. (Chief Financial Officer) Sale 2,784 8.96 24,944
2018-10-15 Loh Evan (President, COO and CMO) Sale 5,200 8.96 46,592
2018-10-15 Haskel William M. (Sr. VP, Sec. & General Counsel) Sale 2,231 8.96 19,989
2018-10-15 Bigham Michael (Chairman and CEO) Sale 6,300 8.96 56,448
2018-10-03 Woodrow Adam (VP & Chief Commercial Officer) Sale 8,750 9.82 85,925
2018-10-03 Pagan Douglas W. (Chief Financial Officer) Sale 7,579 9.82 74,425
2018-10-03 Loh Evan (President, COO and CMO) Sale 8,861 9.82 87,015
2018-10-03 Haskel William M. (Sr. VP, Sec. & General Counsel) Sale 5,860 9.82 57,545
2018-10-03 Bigham Michael (Chairman and CEO) Sale 16,313 9.82 160,193
2018-07-02 Loh Evan (President, COO and CMO) Sale 12,000 9.97 119,640
2018-07-02 Haskel William M. (Sr. VP, Sec. & General Counsel) Sale 7,323 9.97 73,010
2018-07-02 Bigham Michael (Chairman and CEO) Sale 22,500 9.97 224,325
2018-04-09 Woodrow Adam (VP & Chief Commercial Officer) Sale 5,700 12.70 72,390
2018-04-09 Pagan Douglas W. (Chief Financial Officer) Sale 5,237 12.70 66,509
2018-04-09 Loh Evan (President, COO and CMO) Sale 8,084 12.70 102,666
2018-04-09 Haskel William M. (Sr. VP, Sec. & General Counsel) Sale 3,361 12.70 42,684
2018-04-09 Bigham Michael (Chairman and CEO) Sale 8,700 12.70 110,490
2018-02-06 Woodrow Adam (VP & Chief Commercial Officer) Sale 11,000 13.77 151,470
2018-02-05 Woodrow Adam (VP & Chief Commercial Officer) Sale 3,333 14.22 47,395
2018-02-05 Pagan Douglas W. (Chief Financial Officer) Sale 16,291 14.22 231,658
2018-02-05 Loh Evan (President, COO and CMO) Sale 3,040 14.22 43,228
2018-02-05 Radie Robert S (Director) Sale 3,000 14.22 42,660
2018-02-05 Dietz Thomas John (Director) Sale 2,100 14.22 29,862
2018-02-05 Haskel William M. (Sr. VP, Sec. & General Counsel) Sale 1,081 14.22 15,371
2018-02-05 Bigham Michael (Chairman and CEO) Sale 4,000 14.22 56,880
2018-02-02 Bigham Michael (Exec. Chairman of the Board) Option Ex 23,255 4.30 99,996
2017-07-19 Loh Evan (President, COO and CMO) Option Ex 39,478 4.30 169,755
2017-07-19 Bigham Michael (Chairman and CEO) Option Ex 23,255 4.30 99,996
2017-07-05 Woodrow Adam (VP & Chief Commercial Officer) Sale 3,800 23.58 89,600
2017-07-05 Pagan Douglas W. (Chief Financial Officer) Sale 4,139 23.58 97,593
2017-07-05 Loh Evan (President, COO and CMO) Sale 4,351 23.58 102,592
2017-07-05 Haskel William M. (Sr. VP, Sec. & General Counsel) Sale 2,461 23.58 58,027
2017-07-05 Bigham Michael (Chairman and CEO) Sale 5,075 23.58 119,663
2017-06-19 Pagan Douglas W. (Chief Financial Officer) Sale 4,595 25.00 114,875
2017-02-06 Pagan Douglas W. (Chief Financial Officer) Sale 3,405 15.11 51,452
2017-02-06 Loh Evan (President, COO and CMO) Sale 3,106 15.11 46,934
2017-02-06 Bigham Michael (Chairman and CEO) Sale 5,000 15.12 75,575
2016-06-27 Lim Richard J. (Director) Buy 461,538 13.00 5,999,994
2016-06-27 Omega Fund Iv, L.p. (10% Owner) Buy 461,538 13.00 5,999,994
2016-06-23 Bigham Michael (Chairman and CEO) Buy 20,000 13.45 269,020
2015-12-11 Loh Evan (President and CMO) Buy 900 16.67 15,003
2015-12-10 Loh Evan (President and CMO) Buy 1,400 17.00 23,800
2015-11-16 Loh Evan (President and CMO) Buy 3,700 16.16 59,792
2015-05-29 Hbm Healthcare Investments (cayman) Ltd. Sale 10,000 29.89 298,860
2015-05-28 Hbm Healthcare Investments (cayman) Ltd. Sale 10,580 31.84 336,846

Insider trading activities including stock purchases, stock sales, and option exercises of NOVC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Paratek Pharmaceuticals, Inc. (symbol NOVC, CIK number 1178711) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.